compound glp-1 medications What Are Compounded Medications? Despite FDA ruling, compounded GLP-1s

Here we highlight data informing the safety, efficacy, and potential utility of new and emerging glucagon-like peptide-1 medicines

What effects might exenatide have on non-motor symptoms in Parkinsons disease: a post hoc analysis

Some report that lower doses, including approaches like low-dose semaglutide or semaglutide microdosing, feel easier to tolerate and less disruptive to daily routines, particularly early in treatment

The therapeutic utility of native GLP-1 is limited by its rapid degradation [2], primarily mediated by dipeptidyl peptidase-4 (DPP-4) and secondarily by neutral endopeptidases (NEPs) and renal clearance [3, 4]

Others report issues with the sparse patient portal and communication gaps